N | Normal in both years | Delayed in One/two years | Chi-square | p-value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Age group | |||||||
2–9 | 25 | 6 | 24.0 | 19 | 76.0 | 0.048 | 0.826 |
10–18 | 37 | 8 | 21.6 | 29 | 78.4 | ||
Gender | |||||||
Male | 30 | 11 | 36.7 | 19 | 63.3 | 6.597 | 0.010 |
Female | 32 | 3 | 9.4 | 29 | 90.6 | ||
Nationality | |||||||
UAE | 30 | 9 | 30.0 | 21 | 70.0 | 3.487 | 0.175 |
Arabs | 9 | 3 | 33.3 | 6 | 66.7 | ||
Non-Arabs | 21 | 2 | 9.5 | 19 | 90.5 | ||
DFO (Deferoxamine) Chelation Drug | |||||||
No | 50 | 12 | 24.0 | 38 | 76.0 | 0.298 | 0.717 |
Yes | 12 | 2 | 16.7 | 10 | 83.3 | ||
DFP (Deferiprone) Chelation Drug | |||||||
No | 59 | 13 | 22.0 | 46 | 78.0 | 0.209 | 0.543 |
Yes | 3 | 1 | 33.3 | 2 | 66.7 | ||
DFX (Deferasirox) Chelation Drug | |||||||
No | 15 | 3 | 20.0 | 12 | 80.0 | 0.075 | 1.000 |
Yes | 47 | 11 | 23.4 | 36 | 76.6 |